Researchers develop pancreatic beta-cell restoring therapy for treating type 1 diabetes

Researchers have successfully treated type 1 diabetes in mice using pancreatic beta-cell, target-specific, chimeric antigen-receptor (CAR) regulatory T cells (Tregs), and demonstrated the feasibility of their approach to treat the human condition according to new data.

from Top Health News -- ScienceDaily https://ift.tt/c8fDIRq